4.4 Article

Cecal Ligation Puncture Procedure

期刊

出版社

JOURNAL OF VISUALIZED EXPERIMENTS
DOI: 10.3791/2860

关键词

Medicine; Issue 51; sepsis; systemic inflammation; infection; septic shock; animal model

资金

  1. Pennsylvania Department of Health
  2. Alfonso Martin Escudero Foundation

向作者/读者索取更多资源

Human sepsis is characterized by a set of systemic reactions in response to intensive and massive infection that failed to be locally contained by the host. Currently, sepsis ranks among the top ten causes of mortality in the USA intensive care units (1). During sepsis there are two established haemodynamic phases that may overlap. The initial phase (hyperdynamic) is defined as a massive production of pro inflammatory cytokines and reactive oxygen species by macrophages and neutrophils that affects vascular permeability (leading to hypotension), cardiac function and induces metabolic changes culminating in tissue necrosis and organ failure. Consequently, the most common cause of mortality is acute kidney injury. The second phase (hypodynamic) is an anti-inflammatory process involving altered monocyte antigen presentation, decreased lymphocyte proliferation and function and increased apoptosis. This state known as immunosuppression or immune depression sharply increases the risk of nocosomial infections and ultimately, death. The mechanisms of these pathophysiological processes are not well characterized. Because both phases of sepsis may cause irreversible and irreparable damage, it is essential to determine the immunological and physiological status of the patient. This is the main reason why many therapeutic drugs have failed. The same drug given at different stages of sepsis may be therapeutic or otherwise harmful or have no effect (2,3). To understand sepsis at various levels it is crucial to have a suitable and comprehensive animal model that reproduces the clinical course of the disease. It is important to characterize the pathophysiological mechanisms occurring during sepsis and control the model conditions for testing potential therapeutic agents. To study the etiology of human sepsis researchers have developed different animal models. The most widely used clinical model is cecal ligation and puncture (CLP). The CLP model consists of the perforation of the cecum allowing the release of fecal material into the peritoneal cavity to generate an exacerbated immune response induced by polymicrobial infection. This model fulfills the human condition that is clinically relevant. As in humans, mice that undergo CLP with fluid resuscitation show the first (early) hyperdynamic phase that in time progresses to the second (late) hypodynamic phase. In addition, the cytokine profile is similar to that seen in human sepsis where there is increased lymphocyte apoptosis (reviewed in 4,5). Due to the multiple and overlapping mechanisms involved in sepsis, researchers need a suitable sepsis model of controlled severity in order to obtain consistent and reproducible results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Meeting Abstract Biotechnology & Applied Microbiology

Gene Edition for Wiskott-Aldrich Syndrome Gene Therapy

Francisco Martin, Pilar Munoz, Marien Cobo, Almudena Sanchez-Gilabert, Pedro Real, Veronica Ramos, Philip D. Gregory, Michael C. Holmes, Miguel G. Toscano

MOLECULAR THERAPY (2015)

Article Biotechnology & Applied Microbiology

SCL/TAL1-mediated Transcriptional Network Enhances Megakaryocytic Specification of Human Embryonic Stem Cells

Miguel G. Toscano, Oscar Navarro-Montero, Veronica Ayllon, Veronica Ramos-Mejia, Xiomara Guerrero-Carreno, Clara Bueno, Tamara Romero, Mar Lamolda, Marien Cobo, Francisco Martin, Pablo Menendez, Pedro J. Real

MOLECULAR THERAPY (2015)

Article Biotechnology & Applied Microbiology

Absence of WASp Enhances Hematopoietic and Megakaryocytic Differentiation in a Human Embryonic Stem Cell Model

Miguel G. Toscano, Pilar Munoz, Almudena Sanchez-Gilabert, Marien Cobo, Karim Benabdellah, Per Anderson, Veronica Ramos-Mejia, Pedro J. Real, Olaf Neth, Agueda Molinos-Quintana, Philip D. Gregory, Michael C. Holmes, Francisco Martin

MOLECULAR THERAPY (2016)

Review Biochemistry & Molecular Biology

The 'Omics' of Amyotrophic Lateral Sclerosis

Diana Caballero-Hernandez, Miguel G. Toscano, Marta Cejudo-Guillen, Maria L. Garcia-Martin, Soledad Lopez, Jaime M. Franco, Francisco J. Quintana, Cintia Roodveldt, David Pozo

TRENDS IN MOLECULAR MEDICINE (2016)

Article Medicine, Research & Experimental

Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies

Miguel G. Toscano, Jeroen van der Velden, Sybrand van der Werf, Machteld Odijk, Ana Roque, Rafael J. Camacho-Garcia, Irene G. Herrera-Gomez, Irene Mancini, Peter de Haan

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)

Article Multidisciplinary Sciences

LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus

Nadia Cobo-Vuilleumier, Petra I. Lorenzo, Noelia Garcia Rodriguez, Irene de Gracia Herrera Gomez, Esther Fuente-Martin, Livia Lopez-Noriega, Jose Manuel Mellado-Gil, Silvana-Yanina Romero-Zerbo, Mathurin Baquie, Christian Claude Lachaud, Katja Stifter, German Perdomo, Marco Bugliani, Vincenzo De Tata, Domenico Bosco, Geraldine Parnaud, David Pozo, Abdelkrim Hmadcha, Javier P. Florido, Miguel G. Toscano, Peter de Haan, Kristina Schoonjans, Luis Sanchez Palazon, Piero Marchetti, Reinhold Schirmbeck, Alejandro Martin-Montalvo, Paolo Meda, Bernat Soria, Francisco-Javier Bermudez-Silva, Luc St-Onge, Benoit R. Gauthier

NATURE COMMUNICATIONS (2018)

Article Immunology

How Simian Virus 40 Hijacks the Intracellular Protein Trafficking Pathway to Its Own Benefit ... and Ours

Miguel G. Toscano, Peter de Haan

FRONTIERS IN IMMUNOLOGY (2018)

Article Cell & Tissue Engineering

Mesenchymal Stromal Cells Express GARP/LRRC32 on Their Surface: Effects on Their Biology and Immunomodulatory Capacity

Ana Belen Carrillo-Galvez, Marien Cobo, Sara Cuevas-Ocana, Alejandra Gutierrez-Guerrero, Almudena Sanchez-Gilabert, Pierpaolo Bongarzone, Angelica Garcia-Perez, Pilar Munoz, Karim Benabdellah, Miguel G. Toscano, Francisco Martin, Per Anderson

STEM CELLS (2015)

Article Multidisciplinary Sciences

Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells

Karim Benabdellah, Pilar Munoz, Marien Cobo, Alejandra Gutierrez-Guerrero, Sabina Sanchez-Hernandez, Angelica Garcia-Perez, Per Anderson, Ana Belen Carrillo-Galvez, Miguel G. Toscano, Francisco Martin

SCIENTIFIC REPORTS (2016)

Review Biotechnology & Applied Microbiology

Viral gene delivery vectors: the next generation medicines for immune-related diseases

Peter De Haan, Ferdy R. Van Diemen, Miguel G. Toscano

Summary: Viruses are efficient gene delivery vectors for therapies, with replication competent and defective vectors inducing strong immune responses for cancer treatments and genetic disorder therapies. Different viral vectors have applications in various disease treatments and pathogenesis studies.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Medicine, Research & Experimental

GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells

Noelia Arroyo, Laura Villamayor, Irene Diaz, Rita Carmona, Mireia Ramos-Rodriguez, Ramon Munoz-Chapuli, Lorenzo Pasquali, Miguel G. Toscano, Franz Martin, David A. Cano, Anabel Rojas

Summary: GATA4 plays a crucial role in the deactivation and activation of hepatic stellate cells, and therefore in liver fibrosis. Inducing deactivation of hepatic stellate cells, GATA4 may serve as a promising therapeutic target for liver fibrosis.

JCI INSIGHT (2021)

Meeting Abstract Biotechnology & Applied Microbiology

Comparison of genome editing tools for Wiskott-Aldrich syndrome gene therapy

A. Gutierrez-Guerreo, S. Sanchez-Hernandez, G. Galvani, J. Pinedo-Gomez, M. G. Toscano, M. Cobo, P. D. Gregory, M. C. Holmes, K. Benabdellah, F. Martin

HUMAN GENE THERAPY (2016)

Meeting Abstract Biotechnology & Applied Microbiology

Improving gene edition tools for Wiskott-Aldrich Syndrome gene therapy.

A. Gutierrez-Guerrero, S. Sanchez-Hernandez, G. Galvani, M. G. Toscano, M. Cobo, P. D. Gregory, M. C. Holmes, K. Benabdellah, F. Martin

HUMAN GENE THERAPY (2015)

Meeting Abstract Hematology

SCL/TAL1-MEDIATED TRANSCRIPTIONAL NETWORK ENHANCES MEGAKARYOCYTIC SPECIFICATION OF HUMAN EMBRYONIC STEM CELLS

Panlo Menendez, Miguel Toscano, Oscar Navarro-Montero, Veronica Ayllon, Veronica Ramos-Mejia, Clara Bueno, Marien Cobo, Francisco Martin, Pedro Real

EXPERIMENTAL HEMATOLOGY (2014)

Meeting Abstract Biotechnology & Applied Microbiology

Development of ZFN-based pre-clinical in vitro cell model in human embryonic stem cells for Wiskott-Aldrich syndrome

P. Munoz Fernandez, M. Garcia Toscano, M. Cobo Pulido, A. Sanchez Gilabert, K. Benabdellah, A. Gutierrez Guerrero, P. Anderson, M. Holmes, P. D. Gregory, F. Martin Molina

HUMAN GENE THERAPY (2013)

暂无数据